Clinton, Dole Discuss Health Care On The Web

4 November 1996

In an on-line interview published on the World Wide Web by Medline Industries (www.medline.net), US President Bill Clinton and Republican presidential candidate Bob Dole were asked what part they saw the US government playing in providing health care.

Pres Clinton said the system's primary role is to set high standards for quality. He has signed the bill ending "drive-by deliveries," supported "anti-gag" legislation and set up a non-partisan advisory panel focusing on quality assurance and consumer protection, he said. His balanced budget proposal would help provide coverage for those between jobs, and he has worked to make coverage more affordable and available through voluntary purchasing coalitions for small businesses. If re-elected, he will continue to give the states flexibility to administer Medicaid, while modernizing and strengthening Medicare. Insurers and health plans should enhance quality and improve the care they provide, and compete on quality and costs. While the public and private system should work to provide more affordable care, people should take responsibility to buy health care for themselves and their families.

Mr Dole said the Kassebaum-Kennedy reform was a carefully crafted blueprint for future legislation, while Pres Clinton's 1994 plan would have turned the system upside down. The system has thrived due to strong market orientation and government's limited but important role, mainly providing aid to the poor and elderly and supporting clinical training and research.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight